Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
Profound Medical Corp. announced new data from its CAPTAIN randomized controlled trial demonstrating that the TULSA Procedure results in no median change in penile length and superior preservation of erectile function and urinary continence compared to robotic radical prostatectomy in intermediate-risk prostate cancer patients. The results were pre…